Quant Mid Cap Fund

quant Mutual Fund Β· FM: Sanjeev Sharma, Ankit A. Pande, Sandeep Tandon, Varun Pattani, Sameer Kate, Ayusha Kumbhat, Yug Tibrewal Β· INF966L01887 Β· Direct

NAV β‚Ή245.50 AUM β‚Ή8107 Cr as of 22 Sep 2026

Portfolio as of Jul 2026 Β· Last Update: 16-Aug-2026 05:02 PM IST

+ Track Fund

Returns

1D1M3M6M1Y3Y5YRank (1Y)TER
Fund -0.2% -2.5% -1.8% +14.2% +3.8% +11.2% +15.1% 24/31 1.18%
Equity allocation
81.36%
Non-equity allocation (combined)
18.64%

All Equity Holdings (23) as of Jul 2026

# Company Value (β‚Ή Cr) % of AUM Change
1 Aurobindo Pharma Limited 806.5 9.95% β€”
2 Lloyds Metals And Energy Limited 751.5 9.27% β€”
3 Tata Communications Limited 689.2 8.50% β€”
4 IRB Infrastructure Developers Limited 499.1 6.16% β€”
5 Indus Towers Limited 482.2 5.95% β€”
6 Premier Energies Limited 412.9 5.09% β€”
7 Bharat Heavy Electricals Ltd 377.4 4.65% β€”
8 ICICI Bank Limited 375.4 4.63% β€”
9 Nippon Life India Asset Management Ltd 367.9 4.54% β€”
10 LG Electronics India Limited 318.2 3.92% β€”
11 Linde India Ltd. 289.8 3.57% β€”
12 Adani Energy Solutions Limited 284.6 3.51% β€”
13 JSW Infrastructure Limited 212.3 2.62% β€”
14 IPCA Laboratories Ltd 139.8 1.72% β€”
15 Persistent Systems Limited 138.0 1.70% β€”
16 UNITED BREWERIES LIMITED 105.5 1.30% β€”
17 AWL Agri Business Limited 94.0 1.16% β€”
18 UPL Limited 70.3 0.87% β€”
19 L&T Technology Services Limited 45.2 0.56% β€”
20 Godrej Properties Limited 43.4 0.54% β€”
21 Cochin Shipyard Limited 39.0 0.48% β€”
22 Ambuja Cements Ltd 27.3 0.34% β€”
23 Glaxosmithkline Pharmaceuticals Ltd 26.8 0.33% β€”

All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.